A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
CompletedNCT00622765
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Metabolic Diseases, Nutritional and Metabolic Diseases, Nutrition Disorders +2
Start: 2007-11-30End: 2008-06-30Updated: 2014-05-13
A Study of the Safety of R256918 in Obese Patients
CompletedNCT01041677
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Metabolic Diseases, Nutritional and Metabolic Diseases, Nutrition Disorders +2
Start: 2008-02-29End: 2008-10-31Updated: 2013-01-24